Abstract

Evidence-based recommendations on fluocinolone acetonide intravitreal implant (Iluvien) for treating chronic diabetic macular oedema in adults.

Guidance development process

How we develop NICE technology appraisal guidance

Is this guidance up to date?

We reviewed the evidence in June 2018 and we are updating the guidance.